In 2022, the Global Genome Sequencing Equipment/Systems Market was valued at $13.34 billion, and is projected to reach a market size of $31.41 billion by 2030. Over the forecast period of 2023-2030, market is projected to grow at a CAGR of 11.3%. Growing application of NGS in precision medicine and molecular diagnostics, declining costs of genome sequencing, and increasing government funding to support genomics projects are some factors majorly driving the growth of the market.
Industry Overview:
Genome sequencing systems are used to determine the nucleotide sequence of DNA, and it plays a key role in mapping the human genome. Many sequencing methods including Sanger sequencing, next-generation sequencing, and third-generation sequencing have a widespread adoption to determine genome sequencing cost-effectively and reduced time. The declining costs of genome sequencing and continuous advancements in next-generation sequencing systems is a key factor driving the market growth. Genome sequencing systems have wide use in biomarker discovery, agrigenomics, reproductive health, HLA typing, and, forensics, among others. Advancements in sequencing technology and Bioinformatics have enabled better identification of DNA variations. These advancements also aid in determining variants that pose an increased risk for disease. A large number of genes can be tested in a single diagnostic platform and at the same time with the widespread use of Next Generation Sequencing (NGS) and Whole-genome Sequencing (WGS), thus expanding the utility of DNA sequencing in clinical diagnosis. The emergence of global-scale projects related to NGS protocols provides new foundational knowledge about oncology and precision medicine. The growing incidence of cancer, increasing government funding to support genomics projects, increasing applications of NGS in cancer research, and the entry of new players in the genome sequencing systems market, are boosting the market. Furthermore, rising demand for quick and easy clinical diagnosis and increasing funding from public and private sectors are also contributing to the market growth. Key market players are heavily investing in cost-effective and enhanced consumables and portable sequencing technologies which is providing thrust to the global genome sequencing systems market.
COVID-19 outbreak impact on Genome Sequencing Equipment/Systems Market
An exponential increase in the COVID-19 cases has driven the demand for genome sequencing technologies in rapid genomic sequencing projects to detect viral spread and manage treatments in the future. The National Health Service of U.K., Genomics England, along with Genetics of Mortality in Critical Care formed a partnership with Illumina to develop whole-genome sequences of 35,000 COVID-19 affected citizens in the U.K. in May 2020. This has propelled the demand for DNA sequencing in the diagnosis of COVID-19. CVS Health launched Transform Oncology Care, a precision medicine program launched in December 2019, that leverages genomics technology in personalized cancer treatment plans. DNA sequencing has shifted proteomic and genomic research as it is a highly accurate and high-throughput technology used in various applications, including WGS, de novo assembly, and DNA resequencing. This technology is readily adopted in many academic research institutes for research studies. Illumina initiated NovaSeq 6000 Sequencing System at the Whitehead Institute for Biomedical Research, the U.S., in 2020. The COVID-19 pandemic has disrupted supply chains, impeded the shipping and delivery of products to customers, and restricted sales operations. This led to a decline in the sales of sequencing consumables, instrument services, and sequencing services, in 2020. A renewal in testing numbers is witnessed as countries slowly ease restrictions on movement. The COVID-19 pandemic accelerated the development of therapeutic drugs and vaccines and increased the need for developing more simple and precise testing technologies and the growth of testing structures.
MARKET DRIVERS:
NGS tools are used in personalized medicine, to recognize gen expression which aids the development of precision medicine, according to the patient’s characteristics. The discovery of new biomarkers for different diseases, especially cancer, has revolutionized the fields of medical diagnostics. A better understanding of genomics and rapid developments in sequencing technologies have increased the efficiency of biomarkers in disease detection. Precise diagnosis combined with personalized medicine increase survival rates and also reduce the financial burden on national health insurance programs and governments around the world. Several pharmaceutical companies are hugely investing in personalized medicine research which is likely to drive the market growth.
Declining costs of genome sequencing and increasing government funding to support genomics projects are propelling the market growth
The availability of efficient, and advanced NGS systems at low costs, along with the reduced cost of genome sequencing, is driving the adoption of the latest NGS technologies worldwide. Governments in many countries have made significant investments in genomics which have played a key role in the development of new technologies. Such initiatives are likely to increase the usage of genomics products, thereby, driving the overall market growth.
MARKET RESTRAINTS:
The utilization of Genomics data includes different applications namely diagnostics, pharmacogenomics, and toxicogenomics. The scrutiny of massive volumes of data generated in genomics research has been a major restraining factor. Considering the complexities and the demand for profound knowledge in the field of genomics, it is necessary to recruit skilled professionals in analyzing and understanding the results of genomic sequencing data. The dearth of skilled professionals leads to several challenges faced by end-users in analyzing genomic data.
End-user budget constraints in developing economies are restraining the genome sequencing systems market growth
External fundings are majorly responsible for academic research and development activities in developing countries. High-quality and advanced premium equipment and technologies need funding which becomes a restraining factor for many academic and research institutes owing to budget limitations. Concrete results may take time despite continuous efforts by government bodies to provide funds for research. This limits the adoption of NGS technologies in developing countries.
GENOME SEQUENCING EQUIPMENT/SYSTEMS MARKET REPORT COVERAGE:
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2022 - 2030 |
|
Base Year |
2022 |
|
Forecast Period |
2023 - 2030 |
|
CAGR |
11.3% |
|
Segments Covered |
By Products & Services, Technology, Application, End Use and Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regional Scope |
North America, Europe, APAC, Latin America, Middle East & Africa |
|
Key Companies Profiled |
Illumina, Inc., Thermo Fisher Scientific, ABBOTT LABORATORIES, QIAGEN N.V., Agilent Technologies, Inc., Bio-Rad Laboratories, DANAHER CORPORATION, Oxford Nanopore Technologies, Ltd., Myriad Genetics, Inc. F. Hoffmann-La Roche Ltd., Veritas Genetics, PACIFIC BIOSCIENCES OF CALIFORNIA, INC., and BGI |
This research report on the global Genome Sequencing Equipment/Systems Market has been segmented and sub-segmented based on products and services, technology, application, end-use, and region.
Based on Products & Services, the Genome Sequencing Systems Market is segmented into Consumables, Instruments, and Services. The consumables segment held the largest share of the genome sequencing systems market. The widespread usage of consumables in genomic systems and the increasing number of genomic tests performed worldwide are majorly driving the market growth. The constant addition of reagents and kits to make WGS more affordable and accessible drives the segment growth in the genome sequencing systems market. The exclusive reagents and advanced technology platforms of the service providers ensure accurate performance. They provide rapid turnaround time, technical support, and outstanding customer service which is anticipated to drive the services segment at a significant growth rate in the Genome Sequencing Systems market during the forecast period.
Based on Technology, the Genome Sequencing Systems Market is segmented into Sanger Sequencing, Next-Generation Sequencing, and Third Generation DNA Sequencing. The Third-Generation DNA Sequencing segment is projected to witness a significant CAGR during the forecast period in the genome sequencing systems market. This technology helps in addressing the issues of second-generation techniques as it involves easy sample preparation without requiring PCR amplification with faster speed. Moreover, it creates long reads exceeding numerous kilobases to detect repetitive sites of complex genomes.
Next-generation sequencing segment is projected to register a significant market share during the forecast period owing to revolutionary advances in these technologies and the reduced cost of sequencing which has made genome sequencing more accurate, faster, and affordable. Additionally, NGS technology is gaining traction as a routine clinical diagnostic test, specifically with the COVID-19 infection, which positively influences the segment’s revenue share.
Based on Application, the Genome Sequencing Systems Market is segmented into Oncology, Metagenomics, Epidemiology, Drug Discovery and Development, Clinical Investigation, Agrigenomics & Forensics, HLA Typing/Immune System Monitoring, Reproductive Health, Consumer Genomics, and Others. The Drug Discovery and Development segment held the largest share of the genome sequencing systems market. This growth can be attributed to the increasing research on diseases including cancer and genetic disorders and the declining cost of sequencing.
The Oncology segment is anticipated to account for a significant share in terms of revenue during the forecast period owing to the great potential of NGS technology in clinical research and development of cancer diagnostics and therapeutics.
The consumer genomics segment is estimated to witness the fastest growth rate during the forecast period owing to the rapid proliferation in genealogy, paternity testing, and personal health awareness. Biotechnology companies, such as Helix Opto LLC, and AncestryDNA, among others, are involved in the personal genome service in the consumer genomics sector.
Based on End Use, the Genome Sequencing Systems Market is segmented into Academic Research, Pharmaceutical & Biotechnology Companies, Clinical Research, Hospitals & Clinics, and Others. The Academic Research segment registered the largest revenue share in the genome sequencing systems market owing to the wide adoption of Sanger technology and NGS in academic research projects. In addition, increasing funding programs for DNA sequencing products and drug discoveries in these entities is increasing the revenue share. The increasing healthcare expenditure and growing collaborations among leading companies and research institutes are boosting the market growth.
Geographically, the North American Genome Sequencing Equipment/Systems Market accounted for the largest revenue share of the global genome sequencing systems market in 2021. This can be attributed to continuous technological developments, availability of technologically advanced healthcare infrastructure, high investment in R&D activities, and several government initiatives in the region to support research in drug development and treatment of cancer. For instance, BC Cancer Foundation, Personalized Onco-Genomics program utilizes transcriptome and whole-genome analysis to identify cancer genes and corresponding drugs. Such public initiatives are likely to boost the application of such technologies in the region.
The Genome Sequencing Equipment/Systems Market in Europe is anticipated to showcase a high growth rate during the forecast period owing to the increasing incidence of cancer, the increasing applications of next-generation sequencing, growing government funding to encourage genomics projects, and the growing utilization of genomics in personalized medicine.
Asia Pacific Genome Sequencing Equipment/Systems Market is anticipated to witness a lucrative growth rate during the forecast period. This is attributed to the strategic initiatives by international firms to expand their presence given the high customer base. Factors such as the increasing prevalence of chronic diseases, increasing demand for genetic testing, advancements in healthcare infrastructure and research facilities, growing adoption of advanced sequencing processes, and growing investments for effective cost-effective products are driving the growth of genome sequencing equipment/systems market in APAC.
Major Key Players in the Market
Are some of the prominent companies in the genome sequencing systems market.
Notable happenings in the Global Genome Sequencing Equipment/Systems Market in the recent past:
Partnership- In January 2022, Singular Genomics announced its partnership with New England Biolabs® to offer NEBNext® Kits for the G4 Sequencing Platform. This partnership combines G4’s speed, accuracy, flexibility, and power with the NEBNext DNA and RNA Library Prep Kits to offer established and high-quality workflows to customers.
Investment- In March 2022, Illumina, Inc. invested in seven new genomics companies to enter the fourth global funding cycle of Illumina Accelerator Cambridge, UK, and the San Francisco Bay Area.
Expansion- In March 2021, Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostic products expanded diagnostics company partnerships by offering InteliQ products, various barcoded, load-and-go quality control tubes that offer efficiencies in workflow, along with Bio-Rad’s Unity QC data management solutions, which enhance laboratory’s analytical performance.
Product Launch- In January 2020, Illumina unveiled a New Sequencing System, in partnership with Roche, and Software Suite to expedite the availability of distributable NGS-based in-vitro diagnostic tests on the diagnostic (Dx) sequencing systems of Illumina.
Product Launch- In January 2020, Illumina announced designing a regulatory-cleared variety of the high-throughput NovaSeq system to address the rising demand for a Dx platform for supporting deeper sequencing at higher throughput.
Investment- In February 2020, GenapSys, raised USD 75 million to finance the expansion of its tabletop DNA sequencer globally and control coronavirus in the region.
Product Approval- In June 2020, Illumina was granted Emergency Use Authorization (EUA) by the FDA for its COVIDSeq Test in sequencing the full genome of the novel SARS-CoV-2 virus. This test combined with high-throughput NovaSeq 6000 hardware of Illumina has capabilities to process more than 3,000 samples and provides results within 24 hours.
Global automotive lighting refers to all vehicle lighting systems, from headlamps that illuminate the road to taillights that communicate movements. They guarantee motorists and other road users alike safety, visibility, and style. While taillights frequently use LEDs for improved visibility, headlights are available in a variety of technologies, including LED and laser. Interior illumination, DRLs, and signal lights all have a role to play. This market, which was estimated to be worth $33.64 billion in 2022, is anticipated to rise to $67.39 billion by 2030 because of laws, luxury tastes, safety concerns, and technological developments like OLED taillights and adaptive headlights. Anticipate a future dominated by intelligent, connected, personalized, and sustainable lighting systems that enhance the safety, efficiency, and aesthetic appeal of automobiles.
Car lighting works its magic to provide safety, visibility, and style. Headlights cut through the night, taillights express intent, and interiors shine with comfort. The billion-dollar global business is expected to rise due to consumer demand for high-end experiences, safer roads, and cutting-edge technology. Imagine dynamic messages being painted by taillights, headlights that adjust to the road, and interiors that customize their atmosphere. Driven by technological advancements like linked systems and laser beams, this future is calling. Anticipate even more visually attractive, environmentally friendly, and intelligent lighting to illuminate the way ahead, making cars safer, more efficient, and unquestionably cooler.
In the market for automobile lighting, safety is the driving force behind demand from the public and laws. While automated high beams smoothly react to traffic, adaptive headlights modify their beams so as not to blind other people. With visually striking displays, dynamic taillights convey intentions for braking and turning. Beyond these developments, integrated pedestrian identification and lane departure alerts will soon make roads safer and brighter for everyone.
Luxurious automobile lighting creates a distinct visual identity that goes beyond simple illumination. Personalized interior lighting customizes the driving experience by setting the mood with a range of colours and intensities, while intricate designs and distinctive DRLs modify exteriors. As you approach your automobile at night, welcoming lights lead the way, resulting in an interior that is perfectly lit. Not only is this symphony of light aesthetically pleasing, but it also stands as a tribute to luxury. Upcoming developments like gesture-controlled lighting and holographic displays promise to further enhance the experience.
The worldwide automotive lighting market is undergoing a significant transition towards energy-efficient solutions, as environmental concerns gain prominence. LED technology is leading the way, providing a ray of hope for the environment and drivers alike. LED lights beam brighter and use a lot less energy than conventional halogen lamps. There are some tangible advantages to this. For drivers, this translates to increased fuel economy, which lowers petrol prices and lessens reliance on fossil fuels. Greater air quality and a reduction in the transport sector's contribution to climate change are the results of reduced overall emissions.
Although the global automotive lighting business is booming, there are still unknowns. Difficulties impede growth even as innovation propels it with eye catching features like laser beams and adaptable headlights. These technologies are luxury items due to their high cost and difficult integration, which puts producers' abilities to the test. The worldwide patchwork created by unclear legislation limits the potential of innovation. Durability issues persist, particularly when complex systems are subjected to challenging conditions. Ultimately, a lot of drivers still don't fully understand how these improvements can help them. Together, we can overcome these obstacles. The keys to reducing costs are improved production, more seamless integration, and unified regulations. Their full potential can be realized by educating customers about the safety, efficiency, and aesthetic value of these lighting wonders. By working together, we can pave the way for an even brighter and safer future for vehicle lighting.
It is made possible by advanced LED technology, which gives drivers the ability to customize their illumination for the highest level of comfort and flair. Consumers that care about the environment want greener products, and vehicle lighting complies. While solar- and self-powered lighting technologies offer a future powered by clean energy, energy-efficient LEDs lower pollution. The advent of connected lighting systems heralds a new age. Envision automobiles interacting with infrastructure and one another to minimize accidents and enhance traffic efficiency. Integrated headlights with pedestrian recognition provide unmatched safety, while dramatic taillights with eye-catching displays alert onlookers to your intentions. The possibilities are endless in the future. Gesture-controlled interior illumination, holographic displays projected onto the road, and even light fixtures with self-healing capabilities.
Due to laws requiring safety features like headlights, taillights, and brake lights, exterior lighting presently holds the most market share in the vehicle lighting industry. The dominance of this market is partly attributed to advancements in safety-focused technologies such as adaptive headlights and daytime running lights. The market value of external lighting is increased by the quick adoption of technology like LED bulbs and laser lights, which improve performance and aesthetics. Conversely, the interior lighting market is expected to increase at the fastest rate in the upcoming years. Innovations like ambient lighting and technology breakthroughs like LED and OLED displays, driven by consumer demand for comfort and personalisation, open new possibilities. The spread of sophisticated interior lighting systems is further driven by the growing emphasis on safety and the expansion of the luxury car market.
The worldwide vehicle lighting market is currently dominated by halogen because of its more affordable price, advanced technology, and useful illumination. With its dependable supply chain and affordable option for manufacturers and cost-conscious customers, halogen holds the biggest market share. The fastest-growing market right now is LEDs, which are predicted to shortly overtake halogen. The rapid expansion of LEDs is driven by their higher efficiency, longer lifespan, flexibility in design, and technological breakthroughs including enhanced brightness. Because LEDs use less energy and produce fewer emissions and better fuel economy, they are becoming more and more popular in the changing automotive lighting market.
Passenger automobiles rule the worldwide automotive lighting market. The sheer number of passenger cars produced which surpasses that of business vehicles and fuels the need for lighting systems is the primary cause of this popularity. The growing demand for personal automobiles in developing nations is a result of rising disposable income, which in turn drives the rise of the passenger car market. The importance that consumers place on safety and aesthetics elements helps to drive market expansion. But in the upcoming years, the market for electric and hybrid cars is expected to develop at the quickest rate. The exponential rise of the worldwide electric car market, which is still expanding and shows no signs of slowing down, is what is driving this surge. Specialised lighting solutions are required since electric and hybrid vehicles have different lighting requirements because of their specific functionality and design aesthetics.
Most lighting systems sold nowadays are sold by OEMs (Original Equipment Manufacturers), primarily because manufacturers pre-install lighting systems in new cars. But in the next years, the aftermarket is expected to develop at the quickest rate. This spike in demand for replacement parts, especially lighting systems, can be linked to several variables, one of them being the average age of cars. The industry is expanding because of consumers' growing desire to personalise their cars with aftermarket lighting upgrades such LED upgrades and decorative lighting. The availability and affordability of technologies like adaptive headlights and laser lights in the aftermarket, together with other advancements in lighting technology, are driving demand even more. Moreover, the growing market for electric cars (EVs).
Throughout the forecast period, Asia Pacific is anticipated to be the automotive lighting market with the highest profitability. Over the past few years, Asia Pacific countries like China and India have seen notable increases in automotive manufacturing and sales, primarily in the medium-to premium luxury car segment. Asia Pacific is predicted to see an increase in the manufacturing of passenger cars, with India experiencing the strongest growth rate. Depending on the state of the national economy, the area offers a suitable selection of both high-end and cheap cars. For instance, there is a substantial demand for halogen, Xenon/HID, and LED since China and India produce more economy and mid-range automobiles. On the other hand, luxury car adoption rates are greater in South Korea and Japan, where LED lighting is the norm.
A brief shadow was thrown by COVID-19 over the worldwide automotive lighting market. Production was stopped by lockdowns and supply chain disruptions, while luxury lighting upgrades were shelved by consumers on a tight budget. Resources became scarce, and R&D stagnated. Still, the market is recovering thanks to resurgent demand and rearranged priorities. While energy-efficient LEDs are being pushed towards adoption by sustainability, safety concerns are driving interest in features like pedestrian detection and adaptive headlights. The digital push of the epidemic creates opportunities for intelligent, networked lighting systems that may interact with infrastructure and other cars. Ultimately, the industry is positioned to shine brighter, focused on safety, sustainability, and a connected future, even though the pandemic dimmed its brilliance.
A development collaboration between OSRAM Continental and REHAU aims to incorporate lighting into external components, providing automobile manufacturers with innovative lighting options that improve functionality and design flexibility. For rear combination lamps, Hella unveiled a revolutionary lighting innovation called Hella FlatLight technology. A Memorandum of Understanding (MoU) was signed by Samvardhana Motherson Automotive Systems Group BV (SMRPBV), a division of Motherson Group, and Marelli Automotive Lighting to investigate a technology collaboration focused on intelligently lighted external body components. Valeo debuted their revolutionary 360° lighting system at the Shanghai Auto Show. This technology surrounds the car with a band of light, projecting instantaneous, clear signs that other drivers can see from a distance. Pedestrians, cyclists, and scooter riders are especially susceptible to these signals
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
Specify your preferred Countries, Segments, or timeframes
Unlock Country Level Outlook, Trends, Cross-country Comparability, or supply Chain Variations.
Analyst Support
Every order comes with Analyst Support.
Customization
We offer customization to cater your needs to fullest.
Verified Analysis
We value integrity, quality and authenticity the most.
